Skip to main content

Part of the book series: Cancer Treatment and Research ((CTAR,volume 111))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albo D, Wayne JD, Hunt KK, et. al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. American Journal of Surgery 2001;182(4):393–8

    Article  PubMed  CAS  Google Scholar 

  • American Society of Breast Surgeons. Revised Consensus Statement on Guidelines for Performance of Sentinel Lymhpadenectomy for Breast Cancer [bulletin]. August 25, 2000

    Google Scholar 

  • Barnwell JM, Arrendonodo, MA, Kollmorgen D, et al. Sentinel lymph node biopsy in breast cancer. Annals of Surgical Oncology 1998;5(2):126–130

    PubMed  CAS  Google Scholar 

  • Beahrs O, et al. Manual for Staging of Cancer. 4th ed. Philadelphia: Lippincott; 1992.

    Google Scholar 

  • Bland KI. Enhancing the accuracy for predictors of axillary nodal metastasis in Tl carcinoma of the breast: Role of selective biopsy with lymphatic mapping. Journal of the American College of Surgeons 1996;183(3):262–4

    PubMed  CAS  Google Scholar 

  • Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidlines and pitfalls of lymphoscintigraphy and gamma probe detection. Journal of the American College of Surgeons 1998;186(3):275–283

    Article  PubMed  CAS  Google Scholar 

  • Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997;349(9066): 1668–9

    Article  PubMed  CAS  Google Scholar 

  • Cabanes P, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radio therapy in early brest cancer. Lancet 1992;329(8804):1245–1248

    Google Scholar 

  • Cady B. Lymph node metastases. Indicators, but not governors of survival. Archives of Surgery 1984;119(9):1067–72

    PubMed  CAS  Google Scholar 

  • Carter C, Alan C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63(1): 181–7

    PubMed  CAS  Google Scholar 

  • Cox CE, Salud CJ, Harrinton MA. The Role of Selective Sentinel Node Dissection in Breast Cancer. In: Leong SPL, Wong JH, editors. The Surgical Clinics of North America: Sentinel Lymph Nodes in Human Solid Cancer. Philadelphia: WB Saunders, 2000; 80(6): 1759–1777

    Google Scholar 

  • Cox CE, Bass SS, Boulware D, et al. Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma. Annals of Surgical Oncology 1999;6(6):553–561

    Article  PubMed  CAS  Google Scholar 

  • Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Annals of Surgery 1998;227(5):645–51; discussion 651–3

    Article  PubMed  CAS  Google Scholar 

  • Cancer Research Campaign Working Party. Cancer research campaign trial for early breast cancer. Lancet 1980;11:55–60

    Google Scholar 

  • Fisher B, Redmond C, Poisson R, et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with and without irradiation in the treatment of breast cancer. New England Journal of Medicine 1989;320(13):822–828

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, Redmond C, Fisher ER, et al. Ten year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New England Journal of Medicine 1985;312(11):674–682

    PubMed  CAS  Google Scholar 

  • Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surgery, Gynecology and Obstetrics 1981;152(6):765–72

    PubMed  CAS  Google Scholar 

  • Giuliano AE. See One, Do Twenty-Five, Teach One: the implementation of Sentinel Node Dissection in Breast Cancer. Annals of Surgical Oncology 1999a;6:520–521

    Article  PubMed  CAS  Google Scholar 

  • Giuliano AE. Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer. Archives of Surgery 1999b;134(2):195–9

    Article  PubMed  CAS  Google Scholar 

  • Giuliano AE. Intradermal Blue Dye to Identify Sentinel Lymph Node in Breast Cancer. Lancet 1997a;350(9082):958

    Article  PubMed  CAS  Google Scholar 

  • Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. Journal of Clinical Oncology 1997b;15(6):2345–50

    PubMed  CAS  Google Scholar 

  • Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery 1994;220(3):391–8; discussion 398–401

    PubMed  CAS  Google Scholar 

  • Grant RN, Tabah EJ, Adair FE. The surgical significance of the subareolar plexus in cancer of the breast. Surgery 1959;33:71–78

    Google Scholar 

  • Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer Journal 1997;3(6):336–40

    PubMed  CAS  Google Scholar 

  • Haagensen CD, Feind CR, Herter FP, et al. The Lymphatics in Cancer. Philadelphia: WB Saunders; 1972.

    Google Scholar 

  • Harlow SP, Krag DN, Weaver DL, et al. Extra-Axillary Sentinel Lymph Nodes in Breast Cancer. Breast Cancer 1999;6:159–165

    PubMed  Google Scholar 

  • Hayward J. The surgeon’s role in primary breast cancer. Breast Cancer Research and Treatment 1981;1:27–32

    Article  PubMed  CAS  Google Scholar 

  • Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. British Journal of Cancer 1992;66(1):136–138

    PubMed  CAS  Google Scholar 

  • Kern KA, Rosenberg RJ. Preoperative Lymphoscintigraphy During Lymphatic Mapping for Breast Cancer: Improved Sentinel Node Imaging Using Subareolar Injection of Technetium 99m Sulfur Colloid. Journal of the American College of Surgeons 2000;191:479–489

    Article  PubMed  CAS  Google Scholar 

  • Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Annals of Surgery 1999;229(6):860–4; discussion 864–5

    Article  PubMed  CAS  Google Scholar 

  • Kowalsky RJ, Perry JR. Radiopharmaceuticals in Nuclear Medicine Practice. Los Altos: Appleton and Lange, 1987. p.271–314.

    Google Scholar 

  • Krag D. The Sentinel Node for Staging Breast Cancer: Current Review. Breast Cancer 1999;6:233–236

    PubMed  Google Scholar 

  • Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. New England Journal of Medicine 1998;339(14):941–6

    Article  PubMed  CAS  Google Scholar 

  • Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surgical Oncology 1993;2(6):335–9; discussion 340

    Article  PubMed  CAS  Google Scholar 

  • Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable breast cancer. British Journal of Surgery 1980;67(3):170–174

    PubMed  CAS  Google Scholar 

  • Leong SPL, Morita ET, Treseler PA, et al. Multidisciplinary Approach to Selective Sentinel Lymph Node Mapping in Breast Cancer. Breast Cancer 2000a;7(2):105–113

    Article  PubMed  CAS  Google Scholar 

  • Leong SPL, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Annals of Surgical Oncology 2000b;7:361–6

    Article  PubMed  CAS  Google Scholar 

  • Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Archives of Surgery 1997;132(6):666–73; discussion 673

    PubMed  CAS  Google Scholar 

  • Linehan DC, Hill AD, Tran KN, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. Journal of the American College of Surgeons 1999;188(4):377–81

    Article  PubMed  CAS  Google Scholar 

  • McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. British Journal of Surgery 1986;73(4):264–6

    PubMed  CAS  Google Scholar 

  • McMasters KM, Wong SL, Martin RC 2d, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Annals of Surgery 2001;233:676–687

    Article  PubMed  CAS  Google Scholar 

  • Morton DL, Wen DR, Wong JH. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery 1992;127(4):392–9

    PubMed  CAS  Google Scholar 

  • Neiweg OEK, Peterse JL, et al. Identification of sentinel node in patients with breast carcinoma. Ned Tijdschr Geneeskd 1996;140:2235–39

    Google Scholar 

  • Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: Results of a national survery by the American College of Surgeons. Cancer 1980;45(12):2917–24

    PubMed  CAS  Google Scholar 

  • NIHCC. NIoHCc: Treatment of early breast cancer. JAMA 1991;265:391–5

    Google Scholar 

  • O’Hea BHA, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer [see comments]. Journal of the American College of Surgeons 1998;186(4):423–427

    Google Scholar 

  • Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival — a Bayesian metaanalysis. Annals of Surgical Oncology 1999;6(1):109–116

    Article  PubMed  CAS  Google Scholar 

  • Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New England Journal of Medicine 1997;337(14):949–955

    Article  PubMed  CAS  Google Scholar 

  • Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. Journal of Nuclear Medicine 1997;38(3):366–8

    PubMed  CAS  Google Scholar 

  • Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New England Journal of Medicine 1997;337(14):956–962

    Article  PubMed  CAS  Google Scholar 

  • Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. European Journal of Surgical Oncology 1999;25(4):347–51

    Article  PubMed  CAS  Google Scholar 

  • Rouviere H. Anatomie des Lymphatiques de ľHomme. Paris: Masson, 1932.

    Google Scholar 

  • Rutquist L, Petterson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer; long-term follow-up in a randomized clinical trial. Radiotherapy and Oncology 1993;104:26

    Google Scholar 

  • Sappey MPC. Anatomie, physiologie, pathologie des vaisseaux lymphatiques consideres chez I’homme et les vertebres. Paris, DeLahaye A, Lecrosnier, 1874.

    Google Scholar 

  • Schneebaum SSY, Cohen M, et al. Sentinel lymph node localization in breast cancer — A feasibility study. Presented SSO meeting in Atlanta, GA, 1996.

    Google Scholar 

  • Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Annals of Surgery 1997;226(3):271–6

    Article  PubMed  CAS  Google Scholar 

  • Turner-Warwick RT. The lymphatics of the breast. British Journal of Surgery 1953;46:574–82

    Google Scholar 

  • Vendrell-Tome E, Setoain-Quinquer, Domenech-Torne FM. Study of Normal Mammary Lymphatic Drainage Using Radiotracer Isotopes. Journal of Nuclear Medicine 1972;13(11):801–805

    Google Scholar 

  • Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349(9069):1864–7

    Article  PubMed  CAS  Google Scholar 

  • White R, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast; influence of axillary dissection for treatment of T1a and T1b lesions. Journal of the American College of Surgeons 1996;1836):575–522

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Leong, S.P.L. (2002). Selective Sentinel Lymph Node Mapping and Dissection for Breast Cancer. In: Leong, S.P.L. (eds) Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer. Cancer Treatment and Research, vol 111. Springer, Boston, MA. https://doi.org/10.1007/0-306-47822-6_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-47822-6_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7013-6

  • Online ISBN: 978-0-306-47822-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics